GSA CAPITAL PARTNERS LLP - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 87 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.14 and the average weighting 0.3%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$1,240,000
+4.7%
379,244
+35.2%
0.13%
-5.3%
Q2 2021$1,184,000
+100.7%
280,609
+137.3%
0.13%
+35.7%
Q1 2021$590,000
-34.8%
118,249
+65.1%
0.10%
-33.8%
Q4 2020$905,000
+58.8%
71,627
+23.3%
0.15%
+55.8%
Q3 2020$570,000
+229.5%
58,095
+234.8%
0.10%
-1.0%
Q2 2020$173,000
-61.4%
17,351
-64.3%
0.10%
+84.6%
Q4 2019$448,000
+111.3%
48,565
+34.5%
0.05%
+79.3%
Q3 2019$212,000
-76.5%
36,095
-51.8%
0.03%
-68.1%
Q1 2019$903,000
-23.3%
74,820
-20.3%
0.09%
-33.1%
Q4 2018$1,178,000
-53.7%
93,900
-45.2%
0.14%
-3.5%
Q3 2018$2,545,000
+22.2%
171,500
+38.6%
0.14%
+36.9%
Q2 2018$2,082,000
+16.1%
123,700
+78.5%
0.10%
-5.5%
Q4 2017$1,793,000
+412.3%
69,300
+238.0%
0.11%
+473.7%
Q1 2017$350,000
-39.6%
20,500
-63.6%
0.02%
-45.7%
Q4 2016$579,000
+7.8%
56,309
+6.0%
0.04%
+20.7%
Q3 2016$537,000
-68.3%
53,105
-64.8%
0.03%
-69.1%
Q2 2016$1,693,000
+172.2%
150,748
+230.9%
0.09%
+135.0%
Q1 2016$622,000
-58.3%
45,561
-42.1%
0.04%
-45.2%
Q4 2015$1,492,000
+11.3%
78,641
+10.2%
0.07%
+10.6%
Q3 2015$1,340,00071,3870.07%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 2,610$620,000,0006.47%
Parkman Healthcare Partners LLC 1,124,072$4,732,0001.74%
Kynam Capital Management, LP 1,000,000$4,210,0001.08%
EAM Investors, LLC 850,647$3,581,0000.87%
BVF INC/IL 3,629,000$15,278,0000.74%
EAM Global Investors LLC 388,730$1,637,0000.40%
RA Capital Management 3,307,203$13,923,0000.37%
Nantahala Capital Management 1,659,840$6,988,0000.35%
AWM Investment Company, Inc. 504,661$2,125,0000.34%
INGALLS & SNYDER LLC 1,411,153$5,941,0000.31%
View complete list of CONCERT PHARMACEUTICALS INC shareholders